glp-1 breastfeeding Thinking about support while breastfeeding? Watch this first 🩷🩷 GLP-1s and Breastfeeding — Bridges

China's rapid urbanization and changing diets have fueled a growing obesity crisis, with projections showing that by 2030, 70.5% of adults and 31.8% of children may be obese

(The brand-name GLP-1s arent available as generics because the patents havent expiredNovo Nordisk has its US patent on semaglutide until 2032, and Eli Lilly on tirzepatide, until 2036.) But to be clear, compounders do still operate within a regulatory framework, albeit a less stringent one

Just left my appointment

This is mainly because of expanding digital healthcare and home delivery services

doi: 10.1001/jamainternmed.2016.1522

Always consult a qualified healthcare professional before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing